Hewei Li

2.2k total citations · 1 hit paper
36 papers, 1.7k citations indexed

About

Hewei Li is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Hewei Li has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Hewei Li's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers) and Cancer-related molecular mechanisms research (3 papers). Hewei Li is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers) and Cancer-related molecular mechanisms research (3 papers). Hewei Li collaborates with scholars based in China, United States and Germany. Hewei Li's co-authors include F. Stephen Hodi, Jeffrey S. Weber, James Larkin, Ian M. Waxman, Caroline Robert, Joel Jiang, Dirk Schadendorf, Georgina V. Long, Jedd D. Wolchok and Mario Sznol and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Hewei Li

32 papers receiving 1.7k citations

Hit Papers

Safety Profile of Nivolumab Monotherapy: A Pooled Analysi... 2017 2026 2020 2023 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hewei Li China 14 1.1k 417 337 280 156 36 1.7k
Chie Takasu Japan 25 642 0.6× 598 1.4× 504 1.5× 179 0.6× 51 0.3× 170 1.9k
Jianlin Qiao China 20 402 0.4× 612 1.5× 113 0.3× 371 1.3× 121 0.8× 108 1.6k
Liang-Shun Wang Taiwan 30 641 0.6× 951 2.3× 638 1.9× 208 0.7× 87 0.6× 61 2.3k
Patrizia Mondello Italy 21 507 0.5× 372 0.9× 125 0.4× 214 0.8× 173 1.1× 80 1.3k
Xuan Zhao China 24 470 0.4× 659 1.6× 220 0.7× 341 1.2× 78 0.5× 71 1.4k
Mi Ran Yun South Korea 22 558 0.5× 622 1.5× 483 1.4× 195 0.7× 32 0.2× 49 1.4k
Hakan Çamlıca Türkiye 22 526 0.5× 510 1.2× 171 0.5× 197 0.7× 45 0.3× 68 1.5k
Adel Kardosh United States 19 419 0.4× 424 1.0× 142 0.4× 165 0.6× 88 0.6× 75 1.4k
Masanobu Tsubaki Japan 31 848 0.8× 1.2k 2.8× 206 0.6× 194 0.7× 92 0.6× 93 2.2k

Countries citing papers authored by Hewei Li

Since Specialization
Citations

This map shows the geographic impact of Hewei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hewei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hewei Li more than expected).

Fields of papers citing papers by Hewei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hewei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hewei Li. The network helps show where Hewei Li may publish in the future.

Co-authorship network of co-authors of Hewei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hewei Li. A scholar is included among the top collaborators of Hewei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hewei Li. Hewei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hewei, et al.. (2024). Out-of-pocket medical expenditures, remittances and health outcomes in China. African Journal of Reproductive Health. 28(8). 122–132.
2.
Liu, Zhiqiang, Shumei Zhong, Yaqi Wu, et al.. (2024). Dietary Antrodia cinnamomea Polysaccharide Intervention Modulates Clinical Symptoms by Regulating Ovarian Metabolites and Restructuring the Intestinal Microbiota in Rats with Letrozole-Induced PCOS. Journal of Agricultural and Food Chemistry. 72(50). 27884–27901. 3 indexed citations
3.
Wang, Siyuan, et al.. (2023). Relationship between nonalcoholic fatty liver disease and bone mineral density in elderly Chinese. Journal of Orthopaedic Surgery and Research. 18(1). 679–679.
4.
Li, Hewei, Sikandar Amanullah, Yu Amanda Guo, et al.. (2023). A single nucleotide mutation in ClphyB gene is associated with a short lateral branch phenotype in watermelon. Scientia Horticulturae. 321. 112378–112378. 3 indexed citations
6.
Xu, Qi, Jia‐Rui Wu, Yiming Feng, et al.. (2022). Raspberry-like AgBiS2@PVP nanoparticles for enhanced sonodynamic and chemodynamic cancer therapy. Journal of Materials Chemistry B. 10(41). 8514–8524. 14 indexed citations
7.
Cao, Lihong, Chuang Li, Hewei Li, et al.. (2022). Disruption of REC8 in Meiosis I led to watermelon seedless. Plant Science. 323. 111394–111394. 13 indexed citations
8.
Li, Hewei, et al.. (2021). The Rapid Cytological Process of Grain Determines Early Maturity in Weedy Rice. Frontiers in Plant Science. 12. 711321–711321. 4 indexed citations
9.
Hu, Tingting, et al.. (2017). Overexpressed eNOS upregulates SIRT1 expression and protects mouse pancreatic β cells from apoptosis. Experimental and Therapeutic Medicine. 14(2). 1727–1731. 11 indexed citations
10.
Liu, Yan, et al.. (2016). Shikonin inhibits TNF-α production through suppressing PKC-NF-κB-dependent decrease of IL-10 in rheumatoid arthritis-like cell model. Journal of Natural Medicines. 71(2). 349–356. 26 indexed citations
11.
Li, Hewei, et al.. (2014). Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats. International Journal of Pharmaceutics. 466(1-2). 133–138. 52 indexed citations
12.
Li, Hewei, Ling Dong, Xueyan Li, et al.. (2014). Comparison of two approaches of intestinal absorption by puerarin. Journal of Pharmacological and Toxicological Methods. 70(1). 6–11. 16 indexed citations
14.
Tong, Gary, Junsheng Wang, Oleksandr Sverdlov, et al.. (2012). Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men. Clinical Drug Investigation. 32(11). 761–769. 26 indexed citations
15.
Dockens, Randy, Junsheng Wang, Oleksandr Sverdlov, et al.. (2012). A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects. Clinical Pharmacokinetics. 51(10). 681–693. 36 indexed citations
16.
Tong, Gary, Junsheng Wang, Oleksandr Sverdlov, et al.. (2012). A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. British Journal of Clinical Pharmacology. 75(1). 136–145. 12 indexed citations
17.
Li, Hewei. (2011). AIDS molecular epidemiological survey in Laibin. Journal of Tropical Medicine. 1 indexed citations
18.
Tong, Gary, Shu‐Pang Huang, Randy Slemmon, et al.. (2010). P3‐298: The safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of BMS‐708163 in young and elderly subjects. Alzheimer s & Dementia. 6(4S_Part_17). 2 indexed citations
19.
Li, Hewei, et al.. (2006). Quantitative molecular analysis of MCM6 and MCM7 and their association with HPV E6 and E7 mRNA expression, viral load and physical status in invasive cervical carcinoma. Cancer Research. 66. 217–217.
20.
Ladiwala, Uma, Hewei Li, Jack P. Antel, & Joséphine Nalbantoglu. (1999). p53 Induction by Tumor Necrosis Factor‐α and Involvement of p53 in Cell Death of Human Oligodendrocytes. Journal of Neurochemistry. 73(2). 605–611. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026